Rotator Cuff Tear
Conditions
Brief summary
* The purpose of this study is to compare the clinical and anatomical outcomes of rotator cuff repair with Platelet-Rich Plasma (PRP) and conventional rotator cuff repair in treatment of medium to large rotator cuff tears. * PRP application to arthroscopic rotator cuff repair would accelerate recovery after arthroscopic rotator cuff repair in terms of pain relief, functional outcomes, overall satisfaction, and enhance structural integrity of repaired tendon.
Interventions
* Under general anesthesia, the patient was placed in the lazy lateral decubitus position on the operating table. * The surgical area was prepared and draped with Betadine. * Small stab incisions were made in the creation of 4-5 portals as needed. * A scope was explored via the arthroscopic portal into the GH joint & subacromial space. * Repair of full thickness rotator cuff tear was done with suture anchors. * The skin was closed with Nylon or medical staples. * Sterile dressing was applied on surgical wound.
* Under general anesthesia, the patient was placed in the lazy lateral decubitus position on the operating table. * The surgical area was prepared and draped with Betadine. * Small stab incisions were made in the creation of 4-5 portals as needed. * A scope was explored via the arthroscopic portal into the GH joint & subacromial space. * Repair of full thickness rotator cuff tear was done with suture anchors. * After tying sutures of the medial row, PRP gels were applied on the repair site. * The lateral row was secured using suture anchors. * The skin was closed with Nylon or medical staples. * Sterile dressing was applied on surgical wound.
Sponsors
Study design
Eligibility
Inclusion criteria
medium to large rotator cuff tear as a determined by clinical examination and MR prior to surgery.
Exclusion criteria
* previous history of shoulder surgery * acute trauma * chronic dislocation * pyogenic infection * rotator cuff arthropathy with glenohumeral osteoarthritis and superior migration of the humeral head * showed abnormal serological test results * thrombocytopenia (platelets less than 15000 per microliter) * had been received anti-platelet medication * psychiatric problems that precludes informed consent or inability to read or write * other serious problems that preclude participation of the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Constant-Murley shoulder score | Postoperative 3months | The Constant score assesses pain, function, ROM, and strength. Pain is allotted a maximum of 15 points, activities of daily living (function)20 points, ROM 40 points, and strength 25 points. The component scores are summated to achieve a maximum possible total score of 100. |
Countries
South Korea